India restricts pediatric use of Chlorpheniramine Maleate and Phenylephrine Hydrochloride combinations

The Indian government has mandated restrictions on fixed-dose combinations containing Chlorpheniramine Maleate and Phenylephrine Hydrochloride for children under four years old. This regulatory action follows safety concerns regarding the efficacy and potential risks of these common cold formulations in pediatric populations.